17α-Methyl-19-norprogesterone
17α-Methyl-19-norprogesterone (also known as 17α-Methyl-19-norP4) is a synthetic steroid and derivative of progesterone, a natural progestogen. It is specifically a derivative of 19-norprogesterone and is also related to 17α-hydroxyprogesterone.
Chemistry[edit | edit source]
17α-Methyl-19-norprogesterone, as the name implies, is a structural analog of 19-norprogesterone with a methyl group at the 17α position. It is a member of the 17α-alkylated 19-norprogesterone and 17α-hydroxyprogesterone groups of progestins.
Pharmacology[edit | edit source]
As a progestin, 17α-Methyl-19-norprogesterone has progestogenic activity. It binds to and activates the progesterone receptor (PR), which mediates its effects. The medication has strong progestogenic activity and weak glucocorticoid activity but no other hormonal activity.
History[edit | edit source]
17α-Methyl-19-norprogesterone was first described in the literature in 1962. It was never marketed for medical use.
See also[edit | edit source]
Translate: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD